Do elevated free T3 and free T4 indicate thyroid overexposure that increases adrenergic arousal and disrupts sleep and mood?

Thyroid hormone overexposure, marked by elevated levels of free T3 (FT3) and free T4 (FT4), is a clinically recognized driver of sympathetic hyperactivity and significant neuropsychiatric disruption.

Clinical and mechanistic findings

Elevated FT3 and FT4 levels are direct indicators of thyroid hormone overexposure, often resulting from endogenous hyperthyroidism or iatrogenic overtreatment with levothyroxine (T4) or liothyronine (T3). This excess hormone state triggers a cascade of physiological hyperarousal through several key mechanisms:

• Adrenergic sensitization: Thyroid hormones increase the density of $\beta$-adrenergic receptors in various tissues, including the heart and central nervous system. Furthermore, excess hormones amplify the coupling between these receptors and adenylate cyclase, leading to heightened cyclic AMP (cAMP) production. This sensitizes the body to catecholamines, causing tachycardia and increased cardiac output even when adrenaline levels are normal.
• Sleep disruption: Overexposure leads to central nervous system (CNS) excitability and sympathetic nervous system (SNS) hyperactivity. Clinically, this manifests as difficulty falling and maintaining sleep, with studies showing an odds ratio of 5.4 for sleep-onset insomnia in hyperthyroid patients. Mechanistically, this mimics insomnia models of hyperarousal and can reduce total sleep time.
• Mood and anxiety: Elevated thyroid hormones accelerate serotonin turnover and induce hyperactivity of the hypothalamic-pituitary-adrenal (HPA) axis. These changes, combined with adrenergic arousal, drive clinical symptoms of anxiety, restlessness, irritability, and emotional lability. Research indicates that these neuropsychiatric symptoms typically resolve or significantly improve once euthyroidism is restored via dose adjustment or medical intervention.

Considerations

While the physiological link between thyroid excess and arousal is robust, individual sensitivity to free hormone levels can vary. In cases of iatrogenic overexposure (e.g., combination T3/T4 therapy), patients may experience transient peaks in FT3 that exceed reference ranges and trigger these symptoms even if the thyroid-stimulating hormone (TSH) remains within the normal range.

Bottom line

Elevated FT3 and FT4 reliably indicate thyroid hormone overexposure, which drives adrenergic arousal, insomnia, and mood instability by sensitizing $\beta$-adrenergic receptors and altering CNS neurotransmission. Dose normalization is typically effective in resolving these symptoms.